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Background: Lipids are emerging as important constituents of the molecular machinery involved in the formation and
release of exosomes.
Results: The ether lipid precursor hexadecylglycerol stimulates the release and changes the composition of exosomes.
Conclusion: Ether lipids are important modulators of exosome release.
Significance: By knowing the machinery involved in exosome release, it would be possible to modulate this process.
Exosomes are vesicles released by cells after fusion of multi-
vesicular bodies with the plasma membrane. In this study, we
have investigated whether ether lipids affect the release of exo-
somes in PC-3 cells. To increase the cellular levels of ether lip-
ids, the ether lipid precursor hexadecylglycerol was added to
cells. Lipidomic analysis showed that this compound was in fact
able to double the cellular levels of ether lipids in these cells.
Furthermore, increased levels of ether lipids were also found in
exosomes released by cells containing high levels of these lipids.
Interestingly, as measured by nanoparticle tracking analysis,
cells containing high levels of ether lipids released more exo-
somes than control cells, and these exosomeswere similar in size
to control exosomes.Moreover, silver staining andWestern blot
analyses showed that the protein composition of exosomes
released in the presence of hexadecylglycerol was changed; the
levels of some proteins were increased, and the levels of others
were reduced. In conclusion, this study clearly shows that an
increase in cellular ether lipids is associated with changes in the
release and composition of exosomes.
Exosomes are vesicles released by cells to culture media (in
vitro) or to physiological fluids (in vivo) after fusion of multive-
sicular bodies (MVBs)2 with the plasma membrane (1). Exo-
somes have been attributed to several important physiological
and pathological functions, and today they are seen as a novel
way for cell-to-cell communication (2, 3). The release of exo-
somes is the endpoint of a process that can be divided into three
steps as follows: the biogenesis ofMVBs, the transport ofMVBs
to the plasma membrane, and the fusion of the MVBs with the
plasma membrane. It is not clear at the moment how and why
someMVBs are transported to the plasmamembrane to release
exosomes, whereas others fuse with lysosomes to degrade their
content. It is possible that several types ofMVBs coexist (4–6).
Importantly, the list of molecules that regulate the release of
exosomes is growing. Exosome biogenesis starts at the limiting
membrane of endosomes, which then buds and eventually
pinches off into the endosomal lumen generating intraluminal
vesicles (ILVs). Several endosomal sorting complexes required
for transport proteins such asHrs, TSG101, andAlix (7–9) have
been shown to be implicated in this process. In addition, the
sorting ofmolecules into ILVs and/or the formation of ILVs can
occur independently of the endosomal sorting complex
required for transport machinery. It has, for example, been
reported that the tetraspanins CD9 and CD82 (10, 11) and neu-
tral sphingomyelinase 2 (12) can be implicated in the process,
although this is not always the case (13). Themechanismmight
very well be cell type-dependent. Upon maturation, MVBs can
be transported and fuse with the plasma membrane to release
ILVs, now named exosomes, to the extracellular environment.
Several Rab proteins and synaptotagmin-7 have been impli-
cated in these processes (14–17). Despite these interesting
studies, there are still many unanswered questions concerning
the mechanism of exosome release, and additional players will
surely be identified in the coming years.
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Here, we have investigated the possible role of ether phos-
pholipids in exosome release. Ether lipids contain an ether-
linked alkyl or alkenyl chain at the sn-1 position of the glycerol
backbone and a polar headgroup, mainly ethanolamine or cho-
line (18). Ether lipids are prevalent in humans and animals as
structural components of membranes, although their distribu-
tion varies among tissues (19). These lipids are important for
cell physiology, although their biological functions on the
molecular levels are poorly understood. For example, in mice
ether lipid deficiency leads to male infertility, defects in eye
development, and abnormalities in the central nervous system
(20). In addition, altered levels of ether lipids have been noted in
several genetic disorders and pathologies such as Zellweger
syndrome, Alzheimer disease, and diabetes (19–21). Further-
more, ether lipids may serve as a storage depot of polyunsatu-
rated fatty acids or lipidmediators and function as antioxidative
agents (21–25). In fact, a plasmalogen-selective phospholipase
A2 that catalyzes the release of polyunsaturated fatty acid has
been identified (26). Finally, ether lipids have been shown to be
involved in signaling (27, 28), membrane fusion, and trafficking
(29–33). Interestingly, the fusion rate of liposomes containing
plasmenylethanolamine was found to be higher than the fusion
rate of liposomes containing phosphatidylethanolamine in the
presence of calcium (29). In addition, mutations in some of the
genes involved inether lipidbiosynthesiswere reportednotonly to
change the morphology of caveolae, clathrin-coated pits, endo-
plasmic reticulum, and Golgi cisternae, but also to impair the
uptake and recycling of transferrin in human skin fibroblasts (32).
However, the uptake of transferrin is not affected in HEp-2 cells
containing increased levels of ether lipids (34).
One way to change the lipid composition of cells is to grow
cells in the presence of lipid precursors (35). Addition of the
ether lipid precursor sn-1-O-hexadecylglycerol (HG) (Fig. 1),
which enters the biosynthetic pathway after its phosphoryla-
tion by alkylglycerol kinase (18), has been shown to significantly
increase the levels of ether phospholipids in a number of cell
lines (34, 36–38). As control, we have used untreated cells or
cells treated with DL--palmitin (DP), a control substance for
HG that contains an acyl group instead of the ether group (Fig.
1). In this work, we treated human prostate cancer PC-3 cells
with HG to investigate whether increased levels of ether lipids
affect exosome release. Interestingly, our results show that
cells containing higher levels of ether lipids release larger num-
bers of exosomes. Moreover, the protein profile of exosomes
released from cells treated with HG is changed as compared with
the exosomes released from control cells. It is, at the moment,
unclear how HG alters exosome release, but this study demon-
strates that lipids can be important modulators of this process.
EXPERIMENTAL PROCEDURES
Materials—HGwas from Santa Cruz Biotechnology. Proteo-
Silver Plus Silver Stain kit, DP, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), and BSA were pur-
chased from Sigma. EDTA-free protease inhibitor mixture was
fromRoche Applied Science. Bicinchoninic acid (BCA) protein
assay kit was from Pierce (Thermo Scientific, Rockford, IL).
Mini-protean TGX gels and Transfer-Blot Turbo Transfer
Pack were fromBio-Rad. PVDFmembranes and 0.02-mAno-
top 25 filters were from Millipore (Billerica, MA) and What-
man (Dassel, Germany), respectively. The antibodies used for
Western blottingwere as follows: rabbit anti-caveolin-1,mouse
anti-annexin A2, and mouse anti-TSG101 (all three from BD
Biosciences); mouse anti-vinculin (Santa Cruz Biotechnology);
rabbit anti-CD9 and rabbit anti-alkylglycerone phosphate syn-
thase (AGPS) (Abcam, Cambridge, UK); and rabbit anti-Alix
(Merck-Millipore). HRP-conjugated secondary antibodies
were from Jackson ImmunoResearch (West Grove, PA), and
Li-Cor infrared dye secondary antibodies were from Li-Cor
Biosciences (Lincoln, NE). The antibodies used for immuno-
electronmicroscopy were as follows: mouse anti-CD63 (H5C6)
(Developmental Studies Hybridoma Bank, Iowa City, IA) and
rabbit anti-mouse (Dako, Glostrup, Denmark). Protein A-gold
conjugates (10 nm)were purchased fromCellMicroscopyCen-
ter (Utrecht, Netherlands).
Cell Culture and Treatment—The human prostate cancer
epithelial cell line PC-3 was obtained from ATCC (Boras, Swe-
den). PC-3 cells were cultured in DMEM/F-12 GlutaMAX-ITM
(Invitrogen) supplemented with 7% FCS, 100 units/ml penicil-
lin, and 100g/ml streptomycin, in a humidified 5%CO2 atmo-
sphere at 37 °C. Cells were preincubated with 20 M HG (dis-
solved in ethanol), 20 M DP (dissolved in ethanol), or 0.1%
(v/v) ethanol in complete medium for 24 h. At the end of the
incubation, cells were washed twice and incubated again with
the same concentration of the chemicals in serum-freemedium
for 17–19 h. For siRNA treatment, ON-TARGET plus siRNA
oligos against AGPS or ON-target plus nontargeting siRNA
(control) were purchased from Dharmacon RNAi Technolo-
gies (Lafayette, CO). Two different siRNA oligos against AGPS
were used to down-regulate the level of AGPS (oligo1, GCGA-
AUUCCUGAUAUAGUU; oligo2, UCAAGGACCUCGUAU-
GUCA). siRNA oligos were delivered to the cells using Lipo-
fectamineTM RNAiMAX transfection reagent (Thermo Fisher
Scientific, Waltham, MA) following the manufacturer’s protocol.
Two days after transfection, cells were washed twice and incu-
bated for17–19h inserum-freemediumtocollectexosomes.Cells
were lysed 2–3days after transfection tomeasure knockdowneffi-
ciency. Knockdown efficiency after 2 days wasmeasured to check
that the levels of AGPS were reduced before serum-free medium
was added to the cells for the collection of exosomes.
Cell Lysates—PC-3 cells were washed with cold PBS, and
total cell lysates were prepared in lysis buffer (50 mM Tris-HCl,
300 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, pH 7.4) in the
presence of a protease inhibitor mixture. The suspension was
incubated on ice for 20min and centrifuged at 20,000 g for 10
min at 4 °C. The supernatant was collected and stored at
20 °C.
FIGURE 1. Chemical structure of HG and DP.
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Collection of Cells for Lipidomics—Trypsinized PC-3 cells
were pelleted, resuspended in cold PBS, and centrifuged again
at 300  g for 10 min at 4 °C. Finally, the supernatant was dis-
carded, and the cell pellets were stored at 80 °C prior to
analysis.
MTT Assay—A stock solution of MTT was prepared in PBS
at 5 mg/ml. Cells were then treated with 0.5 mg/ml MTT for
3.5 h at 37 °C in a humidified 5% CO2 incubator. Following
incubation, the supernatant was carefully removed, and
dimethyl sulfoxide was added. The plate was read at 515 nm
in a Synergy 2 instrument (BioTek Instruments Inc., Win-
ooski, VT).
Exosome Isolation—Exosomes were isolated from the condi-
tionedmedia of control and treated cells as described elsewhere
(39). Briefly, the conditionedmedia were centrifuged at 300 g
for 10 min, 1,000  g for 10 min, and 10,000  g for 30 min,
discarding the pellet at each step. The supernatants were then
ultracentrifuged at 100,000 g for 70 min. The exosome pellet
was washed with PBS and then centrifuged again at 100,000 g
for 70 min. The exosome pellets were resuspended in an equal
volume of PBS and then used for further analyses. All centrifu-
gation steps were carried out at 4 °C.
ElectronMicroscopy of Exosomes—Exosomes resuspended in
PBS were fixed (4% formaldehyde, 0.2% glutaraldehyde) and
deposited on Formvar/carbon-coated copper grids. For label-
ing, samples on grids were first blockedwith 0.5%BSA and then
successively incubated with mouse anti-CD63 followed by rab-
bit anti-mouse and then by 10-nm protein A-gold conjugates.
Fixative, blocking solution, and antibody dilutions were pre-
pared in PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM
EGTA, and 2 mM MgCl2, pH 6.9). Samples were then con-
trasted and embedded in a mixture of methylcellulose and ura-
nyl acetate. Finally, exosomes were observed in a JEOL-JEM
1230 (JEOL Ltd., Tokyo, Japan) at 80 kV, and pictures were
acquired using aMorada camera and iTEMsoftware (Olympus,
Münster, Germany).
ElectronMicroscopy of Cells—PC-3 cells were incubated with
or without HG as described previously, and BSA-gold, 10 nm,
was added to the cells during the last hour. Cells were then
washed, fixedwith 2%glutaraldehyde in 0.1M cacodylate buffer,
pH 7.2, for 10 min, scraped, and pelleted. Pellets were treated
with 1% osmium tetroxide for 1 h, with 0.5% tannic acid for 30
min, and then with 1% Na2SO4 for 5 min. Finally, the samples
were contrasted en bloc with 4% uranyl acetate, dehydrated
with ethanol, and embedded in Epon. Cells were observed in a
JEOL 1011 microscope. For quantitative analysis, two inde-
pendent sets of sections were used, and 60 cell profiles were
quantified (n 10–20 cells). Only healthymononucleate inter-
phase cellswith the nuclei sectionedwere used. In these cells, all
gold-labeled MVBs (one or more ILVs) were analyzed.
Nanoparticle Tracking Analysis (NTA)—NTA was used to
determine the concentration and the size distribution of exo-
somes. Exosome pellets were resuspended in PBS filteredwith a
0.02-mAnotop 25 filter and vortexed for 1min. Samples were
diluted to bewithin the recommended range (2 108 to 1 109
particles perml). The samples were then loaded into theNS500
instrument (NanoSight, Amesbury, UK) with a syringe pump.
Five videos, each of 60 s, were acquired for every sample under
the flow mode (infusion rate: 30, camera settings: shutter, 600;
gain, 350–450). Videos were subsequently analyzed with the
NTA2.3 software, which identifies and tracks the center of each
particle under Brownian motion to measure the average dis-
tance the particles move on a frame-by-frame basis.
Total ProteinMeasurements—The amount of total protein in
exosomes and cells was determined using a BCA assay kit
according to the manufacturer’s instructions. BSA was used as
standard protein.
SDS-PAGE and Silver Staining—Similar volumes of exo-
somal samples and similar volumes of cell lysates were mixed
with loading buffer, and the samples were run on 4–20% poly-
acrylamide gels. The gels were stained using ProteoSilver Plus
Silver Stain kit following the manufacturer’s protocol.
SDS-PAGE and Immunoblotting—Similar volumes of exo-
somes and similar volumes of cell lysates were solubilized in
loading buffer and run on 4–20% gradient TGX gels. In some
experiments, specific amounts of cellular and exosomal pro-
teins were loaded. The proteins were transferred to PVDF
membranes using a Transfer-Blot Turbo Transfer Pack. Mem-
branes were incubated with the specified primary and second-
ary antibodies. Blots were visualized with the Amersham Bio-
sciences ECLTMPrimeWestern blot detection (GEHealthcare)
on the Universal Hood II scanner (Bio-Rad). In some cases, the
bands were detected using theOdyssey imaging system (Li-Cor
Biosciences).
Annotations of Lipid Species—The lipid classes are abbrevi-
atedasfollows:phosphatidylcholine(PC),phosphatidylethanol-
amine (PE), phosphatidylglycerol (PG), phosphatidylinositol
(PI), phosphatidylserine (PS), phosphatidic acid (PA), and
diacylglycerol (DAG). Diacyl lipid species are listed with the
two fatty acyl groups separated with an underscore, e.g. PC
16:0_18:1. The same annotation is applied for the ether-linked
glycerophospholipids as follows: PC O (alkyl), PC P (alkenyl),
PE O (alkyl), and PE P (alkenyl), e.g. PC O-16:0_18:1. In sphin-
gomyelin (SM), ceramide (Cer), lactosylceramide (LacCer), and
glucosylceramide (GlcCer), the N-amidated fatty acyl groups
are shown after the slash, e.g. SM d18:1/18:1. Although the gly-
cosphingolipids with only one hexose unit are called hexosylce-
ramides, it is expected that almost all of these species are
GlcCer. For lipids where isobaric structures cannot be discrim-
inated, e.g.PE P-16:0_18:1 and PEO-16:1_18:1, both are shown.
The abbreviation PL is used to indicate all phospholipids except
SM. Cholesterol and cholesteryl esters are abbreviated as
CHOL and CE, respectively.
Lipid Extraction—For lipidomic analysis, lipids were
extracted fromPC-3 cells-released vesicles andPC-3 cell lysates
using amodified Folch lipid extraction procedure (40). To have
sufficient exosomes to run the lipidomic analysis, exosomes
collected on several days were pooled and analyzed together.
The corresponding cells were also pooled before analysis.
Known amounts of deuterium-labeled or heptadecanoyl-based
synthetic internal standards were added to the samples for
quantification of the endogenous lipid species (34). For quanti-
fication of free CHOL, an aliquot of each lipid extract was
treated with acetyl chloride to derivatize CHOL to modified
cholesteryl ester species according to Liebisch et al. (41).
Role of Ether Lipids in Exosome Release
FEBRUARY 13, 2015•VOLUME 290•NUMBER 7 JOURNAL OF BIOLOGICAL CHEMISTRY 4227
 at UQ Library on October 4, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Lysates samples were analyzed in three replicates and exosomal
samples in one replicate.
MS Analyses—Molecular glycerophospholipids, glycerolip-
ids, sterols, and sphingomyelin were analyzed by shotgun anal-
ysis on a hybrid triple quadrupole/linear ion trap mass spec-
trometer (5500 QTRAP, AB SCIEX) equipped with a robotic
nanoflow ion source (NanoMateHD, Advion Biosciences) (42).
The analyses were performed in both positive and negative
ionmodes (e.g. [MH] for PL, SM, Cer, GlcCer, and LacCer;
[MNH4] for CE andDAG; and [MH] for phospholipids
with the exception of PC monitored as [M  CH3COO])
using multiple precursor ion scanning and neutral loss-based
methods (40, 43). Derivatized cholesterol was analyzed in pos-
itive ion mode (41). Neutral glycosphingolipids were analyzed
by reverse phase ultra-high pressure liquid chromatography
using an Acquity BEH C18, 2.1 50-mm column with a parti-
cle size of 1.7 m (Waters, Milford, MA) coupled to a hybrid
triple quadrupole/linear ion trap mass spectrometer (5500
QTRAP, AB SCIEX). A 25-min gradient using 10 mM ammo-
nium acetate in water with 0.1% formic acid (mobile phase A)
and 10 mM ammonium acetate in acetonitrile/2-propanol (4:3,
v/v) containing 0.1% formic acid (mobile phase B) was used.
Sphingolipids were monitored using multiple reactions moni-
toring (44).
Data Processing—The MS data files were processed using
Lipid ProfilerTM and MultiQuantTM softwares for producing a
list of lipid names and peak areas. Lipid identificationwas based
on both parent mass and fragment ions and retention time
where applicable. Masses and counts of detected peaks were
converted into a list of corresponding lipid names. Lipids were
normalized to their respective internal standard (34) and sam-
ple volume to retrieve their concentrations. The internal stan-
dards used were as follows: lysophosphatidylcholine (lyso-PC)
17:0; PC 17:0/17:0; PA 17:0/17:0; PE 17:0/17:0; PG 17:0/17:0; PS
17:0/17:0; DAG 17:0/17:0; D6-CE 18:0; D6-CHOL, SM d18:1/
12:0; Cer d18:1/17:0; D3-GlcCer d18:1/16:0; D3-LacCer, d18:1/
16:0; and Gb3 d18:1/17:0. The concentrations of molecular lip-
ids are presented as nanomoles/mg protein and as mol % of
total lipids. Quality control samples were utilized to monitor
the overall quality of the lipid extraction andmass spectrometry
analyses (45). The quality control samples were mainly used to
remove technical outliers and lipid species that were detected
below the lipid class lower limit of quantification. The lipid
species PG, phosphatidylinositol, lyso-PC, and lyso-PE, consti-
tuting together 2% of the total lipid content, were not
included in Fig. 3 due to their low amounts and larger variation
between experiments.We show the lipid species from one such
analysis (performed in triplicate) in which a pooled cell pellet
consisting of cells collected on 10 different days was used. Sim-
ilar results were obtained in an independent lipidomic analysis
(also performed in triplicate) in which a pooled cell pellet con-
sisting of cells collected on 3 different days was used. The con-
centration of lipid classes was calculated by adding the concen-
trations of each of the individual molecular species quantified
within a specific lipid class.
To quantify the levels of proteins in Western blots Quantity
One version 4.6.5 build 094 (Bio-Rad) or ImageJ (Fiji) were
used. SigmaPlot, version 12.5 (Systat Software Inc., San Jose,
CA), was used for statistical analyses. A paired t test was used to
assess whether the changes in the amount of secreted exosomes
from control and treated conditions were significant. The dif-
ference was considered significant for p value less than 0.05 if
not specified otherwise in the text. All experiments were run
independently in duplicate at least three times.
Profiling of the silver-stained gels was performed with Gene-
Tools (version 4.03) (SynGene, Cambridge, UK). For compari-
son, the background was subtracted using a rolling disc of 50
pixels. Peak intensity threshold was held at 1% maximum peak
height. For normalization, volumes were adjusted to control
sample levels.
RESULTS
Ether Lipid Precursor HG Increases the Cellular Levels of
Ether Lipids in PC-3 Cells—In this study, we aimed to investi-
gate whether an increase in the cellular ether lipids affects exo-
some release. The ether lipid precursorHGhas previously been
shown to increase the cellular levels of ether lipids in several cell
lines (34, 36–38). Therefore, we treated PC-3 cells with HG (20
M), DP (20 M), which is a control substance for HG that
contains an acyl group instead of the ether group, or ethanol
(0.1% as control) (Fig. 1). Treatment with HG or DP did not
reveal any toxic effects in PC-3 cells as measured by the trypan
blue assay andMTT assay, althoughHG reduced cell growth by
14% compared with control (data not shown).
FIGURE 2.Changes in lipid classes after treatment of PC-3 cellswithHGor
DP. Cells were treated with HG (20 M), DP (20 M), or ethanol (0.1%, as
control) for 24 h in complete medium and then for 17–19 h with similar sub-
stance concentrations in serum-freemedium. The cellular lipidomewas then
analyzed by MS. The total amount of the different lipid classes is shown as
mol % (note the logarithmic scale) (a) and inpercentageof the control (b). The
figure is based on analysis of three replicates of a pooled cell pellet consisting
of cells collected on 10 different days. Similar results were obtained in an
independent experiment.
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To investigate whether HG changes the cellular levels of lip-
ids in PC-3 cells, we performed lipidomic analyses of control,
HG-, andDP-treated cells and quantified over 250 lipid species.
As shown in Fig. 2, the levels of ether lipids (PE O/PE P and PC
O/PC P),3 were2-fold higher in cells treated with HG than in
control and DP-treated cells. Furthermore, HG treatment also
changed the levels of several other lipid classes, e.g. cholesterol
was increased approximately by 25%, and PC, PE, and SMwere
reduced by 20–30%. These effects seem to be ether lipid-de-
pendent because DP, the fatty acyl analog of HG, did not affect
the levels of these lipid classes (Fig. 2). Also other lipid classes
such as DAG and CE were shown to be reduced by20% after
HG treatment (Fig. 2).Moreover, higher Cer levels, almost sim-
ilar GlcCer levels, and reduced LacCer levels were observed in
HG-treated cells compared with control cells and DP-treated
cells (Fig. 2).
Comparison of Lipid Species in HG-treated Cells, Control
Cells, and DP-treated Cells—The quantification of the major
PC and PEmolecular species is shown in Fig. 3. All the PEO/PE
P species with 16:0 in the sn-1 position were increased in cells
treated with HG (Fig. 3a). Not surprisingly, the effect of HG is
specific for PE ether lipid species with 16:0 in the sn-1 position
because this ether lipid precursor has an alkyl group with 16
carbon atoms (Fig. 3a). Onlyminor differences betweenDP and
control cells were observed (Fig. 3a). The PC ether lipid species
are shown in Fig. 3b. All the PC ether lipids, with the exception
of 18:0_16:0, were increased to some extent in cells treatedwith
HG, although the effect of HGwas larger in species with 16:0 in
the sn-1 position (Fig. 3b). As for PE ether lipids, DP and control
cells were quite similar with respect to the PC ether lipid com-
position (Fig. 3b). All PE species were decreased in HG-treated
3 For lipid abbreviations, see “Annotations of Lipid Species” under “Experi-
mental Procedures.”
FIGURE 3. Quantitative analysis of glycerophospholipids after HG or DP treatment. Cells were treated with HG (20 M), DP (20 M), or ethanol (0.1%, as
control) for 24 h in complete medium and then for 17–19 h with similar substance concentrations in serum-free medium. The cellular lipidome was then
analyzed byMS. This figure shows the concentration (in picomoles/g protein) of themajor species of PE O/PE P (a), PC O/PC P (b), PE (c), and PC (d). To make
the figure easier to read, only species making upmore than 0.04, 0.09, 0.07, and 0.3 pmol/g protein, respectively, are shown. When the MSmethod was not
able to distinguish between the two lipid species, one of the lipid species is in parentheses. The figure is based on analysis of three replicates of a pooled cell
pellet consisting of cells collected on 10 different days. Similar results were obtained in an independent experiment.
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cells, and the effect of DP varied among the different PE lipid
species (Fig. 3c). In particular, one ofmost abundant PE species,
PE 16:0_18:1, was increased after DP treatment (Fig. 3c). HG-
treated cells contained less of all PC species than control cells
(Fig. 3d), including themost abundant PC species, PC 16:0_16:1
and 16:0_18:1. In general, DP and control cells gave similar
results for the PC species (Fig. 3d).
It has recently been shown that HG treatment of HEp-2 cells
can induce changes in the metabolism of glycosphingolipids
(34). The major species of Cer, GlcCer, and LacCer quantified
in this study are shown in Fig. 4. There were higher amounts of
the most abundant Cer species in cells treated with HG (Fig.
4a), whereas GlcCer species (Fig. 4b) and to a larger extent
LacCer species (Fig. 4c) were present in lower amounts in cells
treated with HG. Surprisingly, the DP-treated cells showed
increased levels ofGlcCer and LacCer (Fig. 4), in contrast to our
study in HEp-2 cells where control and DP-treated cells had
very similar levels of these lipid classes (34). It should be noted
that Gb3 species were not shown because they are present in
very low amounts in PC-3 cells (1.0% of GlcCer levels), thus
resulting in high uncertainty in Gb3 data.
Ether Lipid Precursor HG Increases the Exosomal Levels of
Ether Lipids in PC-3 Cells—It has been shown that there is a
specific sorting of lipid classes into exosomes (39, 46–48). Exo-
somes released by PC-3 cells are enriched in CHOL, SM, PS,
and glycosphingolipids, although they contain less PC than the
parent cells (39). Because the addition of the ether lipid precur-
sorHGmodifies the cellular lipidome (Figs. 2–4), we decided to
investigate whether the lipid composition of exosomes released
from PC-3 cells was changed after HG treatment. Exosomes
released during a period of 17–19 h from control, HG-, and
DP-treated cells were isolated from the cell culture medium by
ultracentrifugation as described previously (39). As shown in
Fig. 5, the morphology of the exosomes observed by electron
microscopy was similar in control cells and HG-treated cells
(Fig. 5, a and b). In addition, the exosomal marker CD63 was
present in both exosomal samples, and no membrane frag-
ments were observed in exosomes released by HG-treated cells
(Fig. 5, a and b). Moreover, the size of the exosomes, measured
with NTA, was not affected by HG or DP treatment (Fig. 5, c
and d). Finally, we show that several typical exosomal markers
were enriched in exosomes compared with cellularmembranes
both in control andHG exosomal samples (Fig. 5e). Altogether,
these experiments indicate that the vesicles released by HG-
treated cells are exosomes and not membrane fragments.
Quantitative lipidomic analyses of exosomes released by con-
trol, HG-, and DP-treated were then performed, and the
amounts of the different lipid classes were quantified in percent
of the total amount of lipids in their respective exosome prep-
aration (Fig. 6). These data revealed that, as expected from our
previous study (39), exosomes released from control PC-3 cells
are enriched in CHOL, SM, and glycosphingolipids and con-
tained lower levels of PL than the parent cells (Fig. 6a, left and
middle panels), and there is an6-fold enrichment (6.2 0.3;
S.D., n 3) of lipids/mg of protein in exosomes compared with
the parent cells. Furthermore, exosomes isolated from
DP-treated (Fig. 6b, left and middle panels) and HG-treated
(Fig. 6c, left and middle panels) cells also had a similar lipid
composition. Interestingly, a comparison of the different phos-
pholipid classes (excluding SM) in exosomes released by con-
trol cells and HG- and DP-treated cells revealed that exosomes
released by HG-treated cells contained a much higher percent-
age of ether lipids, especially ether-linked PE (Fig. 6, right pan-
els). Interestingly, the decrease in PS in exosomes from HG-
treated cells compared with control exosomes corresponds to
the increase in ether-linked PE after HG treatment.
Treatment with the Ether Lipid Precursor HG Increases Exo-
some Release in PC-3 Cells—PC-3 cells were pretreated with
HG, DP, or ethanol (0.1% as control) for 24 h, and exosomes
released during a period of 17–19 h in the presence of the sub-
stances were then isolated from the cell culture medium by
ultracentrifugation. Released exosomes were quantified by
FIGURE 4.Quantitative analysis of Cer, GlcCer, and LacCer after HG or DP
treatment. Cells were treated with HG (20 M), DP (20 M), or ethanol (0.1%,
as control) for 24 h in complete medium and then for 17–19 h with similar
substance concentrations in serum-free medium. The cellular lipidome was
then analyzed by MS. This figure shows the concentration (in picomoles/g
protein) of themajor species of Cer (a), GlcCer (b), and LacCer (c). The figure is
based on analysis of three replicates of a pooled cell pellet consisting of cells
collected on 10 different days. Similar results were obtained in an indepen-
dent experiment.
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NTA, and their total protein content was measured using the
BCA assay. Interestingly, treatment with HG increased the
number of secreted vesicles per cell about 2-fold comparedwith
control andDP treatment (Fig. 7a). In accordance with this, the
total exosomal protein content was increased to the same
extent afterHG treatment comparedwith control andDP treat-
ment (Fig. 7b). The total protein level in HG-treated cells was
reduced by 20% (Fig. 7c), in agreement with the observed
reduction in cell growth (data not shown). Finally, to investigate
whether lower levels of ether lipids had the opposite effect on
exosome release than HG, the cellular levels of AGPS, a perox-
isomal enzyme involved in the rate-limiting step of the biosyn-
thetic pathway of ether lipids, were depleted with siRNA. In
particular, this enzyme catalyzes the exchange of an acyl group
for a long-chain alkyl group and forms the ether bond. The two
siRNA oligos that were used reduced the cellular levels of the
enzyme by70%. Based on the reported half-life of this enzyme
(23  12 h) (50) and on the half-life of peroxisomes (2 days)
(51), we cannot expect to achieve a much larger knockdown.
Under these conditions, the amount of exosomes released per
cell, as measured with nanoparticle tracking analysis, was
reduced by15% (Fig. 8).
Protein Profile of Released Exosomes Is Changed byHGTreat-
ment of PC-3 Cells—Because HG treatment increases the num-
ber of released exosomes (Fig. 7), we decided to characterize the
protein composition of exosomes by performing silver staining
of exosomal proteins in polyacrylamide gels (Fig. 9a). The
GeneTools quantification softwarewas used to analyze the pro-
tein profile and total intensity of the silver-stained proteins in
exosomes released from control and HG- and DP-treated cells.
The protein amount of exosomes released by HG-treated cells
increased to190% compared with exosomes released by con-
trol cells. This is in agreement with the results obtained by
measuring the exosomal protein amount with the BCA assay
(Fig. 7b). The protein content of exosomes released by DP-
treated cells was90% that in control exosomes. The positions
of the protein bands in the profiles were highly reproducible
between the samples (Fig. 9). To detect changes in protein com-
position, the profiles were normalized to the same protein level,
i.e. to the same area under the curve. As shown in Fig. 9b, the
normalized profiles revealed some peaks, as the peak at 50 kDa,
thatwere increased in exosomes released fromHG-treated cells
compared with control cells. Conversely, a significant decrease
for the protein peak at 160 kDa and for several peaks below 30
kDa in exosomes released fromHG-treated cells was observed.
A more detailed analysis (intensity values, ratio of signals for
DP-treated and control cells, and for HG-treated and control
cells) of the 12 main peaks can be found in Table 1 and Fig. 9c.
As shown in Table 1, not all the peaks were significantly
changed (p 0.05) compared with the control.
Furthermore,Western blotting was performed to investigate
changes in the amount of several exosome-associated proteins.
Some of these proteins are typically found in exosomes, such as
Alix andTSG101, and others were chosen due to their presence
in PC-3-released exosomes (13). The exosomal samples were
dissolved in similar volumes of sample buffer and applied to
FIGURE 5. HG treatment does not affect the morphology and size of exosomes. PC-3 cells were treated with HG (20 M), DP (20 M), or ethanol (0.1%, as
control) for 24h in completemedium, andexosomes releasedduring aperiodof 17–19h in serum-freemedium in thepresenceofHG,DP, or ethanolwere then
isolated from the cell culture medium by ultracentrifugation. Exosomes (Exo) released from control (Ctrl) cells (a) and HG-treated cells (b) were inspected by
electronmicroscopy. Exosomeswere labeledwithmouse anti-CD63 followed by rabbit anti-mouse and then by 10 nmprotein A-gold conjugates. Vesicle size
was measured by NTA. c, diameter of exosomes that were frequently detected (mode size). d, size distribution of whole exosome population. Error bars show
S.E., n 4. e, indicated amounts of exosomal or cellular proteins were loaded to gels, and typical exosomal markers were analyzed by Western blot.
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FIGURE 6. HG-treated cells release exosomes with high levels of ether lipids. PC-3 cells were treated with HG (20 M), DP (20 M), or ethanol (0.1%, as
control) for 24h in completemedium, andexosomes releasedduring aperiodof 17–19h in serum-freemedium in thepresenceofHG,DP, or ethanolwere then
isolated from the cell culturemediumbyultracentrifugation. Isolated exosomeswere analyzedbyMS. Lipid composition of exosomes releasedby control cells
(a), DP-treated cells (b), and HG-treated cells (c) are shown. PL includes the sum of all phospholipid classes excluding SM. For cells and exosomes, the values
represent percentages of total lipids in cells and exosomes, respectively. For the composition of the PL lipid classes in exosomes, 100% in the right panels
corresponds to thepercentagePL shown in themiddle panels. The figure is basedon theanalysis of either apooled cell pellet or apooledexosomepellet of cells
and exosomes, respectively, collected on 10 different days. Similar results were obtained in an independent experiment.
FIGURE 7. Exosome release is stimulated in HG-treated PC-3 cells. Cells were treated with HG (20 M), DP (20 M), or ethanol (0.1%, as control) for 24 h in
completemedium, and exosomes released during a period of 17–19 h in serum-freemedium in the presence of HG, DP, or ethanolwere then isolated from the
cell culture medium by ultracentrifugation. a, exosome concentration was measured by NTA. The total exosomal (b) and cellular (c) protein content was
measured using the BCA assay. In the figure, error bars show S.E. for n 4. *, p value 0.05 for DP versus control (Ctrl); **, p value 0.05 for both HG versus
control and HG versus DP.
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the gels. Because there are more exosomes released in the pres-
ence of HG, the HG exosomal samples will then contain
approximately double the amount of protein compared with
control exosomes (Fig. 7). This implies that one should expect
to find approximately the double amount of a specific protein in
HG exosomes if the amount of this protein per exosome was
unchanged by HG treatment. As shown in Fig. 10a, none of the
tested proteins showed a 2-fold increase in exosomes released
by HG-treated cells compared with control cells. This indicates
that exosomes isolated in the presence of HG have lower
amounts of these proteins compared with control cells. The
levels of the same proteins in exosomes released by DP-treated
cells were in general similar to control exosomes (Fig. 10a).
Finally, HG treatment did not change the cellular levels of the
five tested proteins (Fig. 10b).With the exception ofAlix, which
showed a large variation between experiments, the levels of the
other proteins in DP-treated cells were also quite similar to
control cells (Fig. 10b).
Quantitative Electron Microscopy Analysis Reveals a Lower
Number of MVBs in HG Cells—As mentioned in the Introduc-
tion, the release of exosomes is the end point of a process that
FIGURE 8. Role of AGPS on exosome release. PC-3 cells were transfected
with control siRNA or with two different siRNA oligonucleotides (50 nM)
against APGS (APGS #1 and APGS #2). After 2 days, serum-free medium was
added, andexosomeswere collected after 17–19h.a, representativeWestern
blots showing the levels of APGS and the internal control GAPDH in the dif-
ferent conditions 3 days after transfection. b, quantification graphs showing
values (% of control) normalized to GAPDH. c, exosome concentration as
measured by nanoparticle tracking analysis. The error bars show S.E. for three
independent experiments performed in duplicate. The reduction was not
statistically significant (n.s.) (p value	0.05). Ctrl, control.
FIGURE 9. Protein profile of exosomes after treatment of PC-3 cells
with HG or DP. Cells were treated with HG (20 M), DP (20 M), or ethanol
(0.1%, as control) for 24 h in complete medium. Exosomes released during
a period of 17–19 h in serum-free medium in the presence of HG, DP, or
ethanol were then isolated from the cell culture medium by ultracentri-
fugation. The exosomal fraction was run on SDS-PAGE, and the proteins
were stained by silver staining. a, silver-stained gel and protein profile in
exosomes released by cells treated in the three conditions. Lane St., stan-
dard. b, protein profile after normalization to the same area under the
curve. c, analyses of the 12 peaks specified in b (see also Table 1). The
values are normalized to control. The panel shows the S.E. of four repli-
cates. A.U., arbitrary units. MW, molecular weight. The figure shows the
results from four replicates.
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can be divided into threemain steps as follows: the biogenesis of
MVBs, the transport ofMVBs to the plasmamembrane, and the
fusion of the MVBs with the plasma membrane. The experi-
ments that we have performed so far show that HG treatment
increases the release of exosomes in PC-3 cells. However, these
experiments do not allow us to establish at what stage HG
affects exosome release. In an attempt to obtain more informa-
tion about the effect of HG, we performed a quantitative anal-
ysis by electron microscopy. Electron micrographs show that
the morphology and size of MVBs and ILVs are quite similar in
control (Fig. 11a) and in HG-treated cells (Fig. 11b). However,
quantification of MVBs and ILVs showed that the numbers of
MVBs per cell profile is lower inHG-treated cells and that these
cells also contain less ILVs per MVB (Fig. 11c). In agreement
with these results, the total number of ILVs per cell profile is
also reduced in HG-treated cells (Fig. 11c). Finally, it should be
mentioned that the number of gold particles perMVBwas quite
similar in control and HG-treated cells (Fig. 11c).
DISCUSSION
Ether lipids have not obtained much attention even though
they constitute a considerable proportion of membrane lipids,
and their absence causes several diseases. Notably, these lipids
play a role in membrane trafficking and fusion (29–33). In this
study, we have investigated how increased levels of ether lipids
affect the release of exosomes from the human prostate cancer
cell line PC-3. The ether lipid precursor HG was used to
increase the cellular levels of ether lipids. Interestingly, HG
treatment of cells induces the release of higher levels of exo-
somes to the extracellular environment. Moreover, these exo-
somes contain much higher levels of ether lipids, especially
ether-linked PE, and their protein composition is altered com-
pared with exosomes released from control cells.
Although an increased level of ether lipids leads to increased
exosome release, one cannot assume that a reduction will lead
to the opposite. There is no reason to expect a linear relation-
ship.However, to investigatewhether a reduction in the cellular
levels of ether lipids interferes with exosome release, the pro-
cess was measured in cells with reduced levels of AGPS, a per-
oxisomal enzyme essential for the biosynthesis of ether lipids.
In these cells, exosome release was slightly reduced. However,
we have to consider that the levels of this enzyme were only
TABLE 1
Intensities (areas under the curve, in arbitrary units) of the 12 main
peaks in silver-stained protein SDS-PAGE of exosomes released from
control (ctrl), DP-treated cells, and HG-treated cells
The values are normalized to control. Ratios were calculated, and significance was
evaluated with a paired t test (p  0.05). Four replicates were used in the calcula-
tions. Boldface cells show significant differences.
Mass
Peak
no. Ctrl DP HG
Ratio
HG/Ctrl
p value
HG/Ctrl
Ratio
DP/Ctrl
p value
DP/Ctrl
kDa
190 1 830.0 896.9 422.0 0.51 0.004 1.08 0.159
120 2 46.3 54.5 80.0 1.73 0.159 1.18 0.088
70 3 84.9 169.7 248.8 2.93 0.006 2.00 0.063
60 4 331.6 745.3 475.5 1.43 0.011 2.25 0.000
50 5 38.7 7.1 108.6 2.80 0.044 0.18 0.328
45 6 92.5 182.6 249.3 2.69 0.108 1.97 0.037
40 7 766.0 694.9 916.2 1.20 0.002 0.91 0.183
34 8 225.3 213.3 299.1 1.33 0.003 0.95 0.153
32 9 326.5 148.9 136.1 0.42 0.000 0.46 0.480
28 10 113.3 28.4 40.4 0.36 0.037 0.25 0.780
22 11 197.2 104.4 87.2 0.44 0.103 0.53 0.607
16 12 118.68 58.81 94.25 0.79 0.102 0.50 0.278
FIGURE 10. Analysis of specific proteins in exosomes by Western blot.
PC-3 cells were incubated with HG (20 M), DP (20 M), or ethanol (0.1%, as
control) for 24 h in complete medium, and then exosomes released during a
periodof 17–19h in serum-freemedium in thepresence ofHG,DP, or ethanol
were isolated from the cell culturemediumby ultracentrifugation. Exosomes
and cellular fractions were run on SDS-PAGE, andWestern blotting was used
to analyze changes of specific proteins. a, representative Western blots and
protein quantification of exosome samples in several experiments. b, repre-
sentativeWestern blots and protein quantification of cellular samples in sev-
eral experiments. Error bars indicate S.E., n 3–4.
FIGURE 11. Electron microscopy analysis of control cells and HG-treated
cells. One hour before the collection of exosomes was stopped, cells were
incubated with BSA-gold 10 nm. Cells were then fixed, and Epon sections
were prepared and visualized by electron microscopy. The figure shows an
electron micrograph of control cells (a) and HG-treated cells (b) containing
MVB (arrow). c, quantitative analysis of MVBs and ILVs in micrographs of con-
trol and HG-treated cells. Two independent sets of sections were used, and
60 cell profiles were quantified (n  10–20 cells). Only healthy mononu-
cleate interphase cellswith the nucleus sectionedwere used. In these cells, all
gold-labeled MVBs (one or more ILVs) were analyzed.
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depleted by70%, probably due to the long half-life of peroxi-
somes and of this enzyme (50, 51).
The release of exosomes is the end point of a process that can
be divided into several steps. At themoment there are notmany
experimental approaches that allow a clear differentiation
between these stages. In this study, we have used quantitative
electron microscopy in an attempt to get more information
about the stage of exosome release that is affected by HG.
The lower number of MVBs per cell profile observed in HG-
treated cells is in agreement with the idea that more MVBs
have fused with the plasma membrane in HG-treated cells
and more ILVs have been released. Considering that ether
lipids have previously been suggested to be implicated in
membrane fusion (29), it is possible that the addition of HG
increases the fusion of MVBs with the plasma membrane.
Moreover, lower numbers of ILVs per MVB are found in
HG-treated cells. This could indicate the possibility that less
mature MVBs with fewer ILVs are left after increased fusion
of mature MVBs with the plasma membrane. It is important
to mention that even if these experiments have provided us
with some clues about the stage of exosome release that may
be affected in HG-treated cells, further experiments are
required to confirm our hypothesis.
Our results suggest thatHG is able to affect protein sorting at
the level ofMVBs and thereby the composition of the ILVs that
later are released as exosomes.We do not know at the moment
how HG exerts this effect. A possibility is that the ether lipid
content of the limiting membrane of MVBs is higher in HG-
treated cells and that this affects the physical properties of this
membrane. In particular, it is possible that mainly the raft
domains at the limitingmembrane ofMVBs are affected byHG
treatment, because it has been reported that some ether lipids
are enriched in lipid rafts (52). This is interesting because raft
domains have been implicated in exosomal protein sorting (46).
It should also be mentioned that not all the vesicular pathways
are changed afterHG treatment.Wehave previously found that
although HG treatment of HEp-2 cells inhibited retrograde
transport of Shiga toxin through theGolgi apparatus (33), there
was no effect on the transport of the plant toxin ricin all the way
from the cell surface, through the Golgi apparatus, and to the
cytosol (34). Furthermore, we have recently reported that HG
treatment of PC-3 cells does not affect the cAMP production
caused by cholera toxin, thus suggesting that the endocytosis
and retrograde trafficking of this toxin, which binds the gangli-
oside GM1, is unaltered (33).
Our lipidomic analyses clearly show that HG increases the
levels of ether lipids in PC-3 cells comparedwith control cells or
cells treated with DP, a substance that contains an acyl group
instead of an ether group.However, HG treatment also induced
changes in other lipid classes suggesting that there is a meta-
bolic link between ether-linked phospholipids and other lipid
classes. We recently showed that the levels of glycosphingolip-
idswere reduced inHEp-2 cells afterHG treatment (34), andwe
observed a similar effect in this study. However, in PC-3 cells,
HG treatment resulted in higher levels of Cer, the substrate for
GlcCer synthesis. This might explain why in PC-3 cells we
observed only small differences between GlcCer in HG-treated
cells and control cells, whereas the LacCer level was much
lower in HG-treated cells. The mechanism behind the effect of
HG in these lipids is not understood at the moment.
Exosomes have a characteristic lipid composition (39, 48,
53). In a previous study of the lipidome of exosomes released
from PC-3 cells, we observed an enrichment of PS 18:0_18:1 in
exosomes compared with cells (39). This enrichment was sim-
ilar to that of CHOL and long-chain sphingolipids (N-amidated
C22 and C24 species). Furthermore, assuming a diameter of 70
nm for exosomes, PS 18:0_18:1 in the inner leaflet could theo-
retically occupy80% of themembrane area occupied by long-
chain sphingolipids in the outer leaflet of exosomes, and we
speculated that this was due to specific interactions between
the two membrane leaflets (39). Such interactions might be
required for exosome formation and for signaling across the
membrane like that observed following binding of Shiga toxin
to its lipid receptor on the outer leaflet of cells (54). Interest-
ingly, in this study control exosomes and exosomes released in
the presence of DP or HG showed ratios of PS 18:0_18:1 to
long-chain sphingolipids (N-amidated C24 and C26 species)
fitting with PS 18:0_18:1 and being able to occupy95, 79, and
71%, respectively, in the inner leaflet of the area covered by
these long-chain sphingolipids in the outer leaflet. It should be
noted that the experimental conditions used in the two studies
were not completely similar, and this may explain why long-
chain glycosphingolipids contributed only 6% to the total long-
chain sphingolipids in exosomes in the previous study (39) but
32–37% in the three exosomal preparations analyzed in this
study. Despite this, we observed similar ratios of PS/sphingo-
lipids in the two studies, and exosomes released by HG- and
DP-treated cells showed similar ratios as in the control exo-
somes. Thus, these data provide further evidence for our previ-
ous theory that there may be “handshaking” between PS
18:0_18:1 on the inner leaflet and long-chain sphingolipids in
the outer leaflet (39).
In conclusion, our studies reveal that ether lipids are able to
modulate the release of exosomes as well as to change the com-
position of exosomes and highlight the importance of lipids in
exosome release.
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